Norwegian robotics startup 1X, backed by OpenAI, has announced plans to begin in-home testing of its bipedal robot, Neo Gamma. According to a report by TechCrunch, the company aims to deploy the robot in “a few hundred to a few thousand” homes by the end of 2024, marking the first time Neo Gamma will be tested outside of controlled lab environments.
Neo Gamma represents 1X’s first foray into bipedal robotics, a challenging yet promising field that aims to create robots capable of navigating human spaces with ease. Unlike wheeled or quadrupedal robots, bipedal designs like Neo Gamma are intended to mimic human movement, allowing them to operate in environments built for people. This makes them potentially invaluable for household tasks, elderly care, and other domestic applications.
The decision to test Neo Gamma in real-world homes underscores 1X’s confidence in the robot’s capabilities. By exposing the robot to the unpredictability of everyday life—such as navigating cluttered spaces, interacting with family members, and performing household chores—the company hopes to gather valuable data to refine its design and functionality. This approach also aligns with OpenAI’s vision of developing artificial intelligence and robotics that can seamlessly integrate into human environments.
1X’s partnership with OpenAI has been instrumental in advancing its robotics technology. OpenAI’s expertise in AI and machine learning has likely contributed to Neo Gamma’s ability to learn and adapt to new tasks, a critical feature for robots intended to assist in diverse home settings. The collaboration highlights the growing synergy between AI and robotics, as companies strive to create machines that are not only physically capable but also intelligent and responsive.
While the deployment of humanoid robots in homes is still in its early stages, 1X’s initiative signals a bold move toward a future where robots become commonplace helpers in daily life. If successful, Neo Gamma could pave the way for a new generation of robots designed to enhance human productivity and quality of life. As testing begins later this year, the world will be watching to see how this ambitious vision unfolds
